Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × Irinotecan × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 62 Pancreatic Neoplasms 29 Neoplasm Metastasis 20 Neuroblastoma 16 Colonic Neoplasms 16 Neoplasms 15 Stomach Neoplasms 13 Rectal Neoplasms 9 Sarcoma, Ewing 8 Rhabdomyosarcoma 7 Esophageal Squamous Cell Carcinoma 7 Ovarian Neoplasms 6 Sarcoma 5 Adenocarcinoma Of Esophagus 5 Small Cell Lung Carcinoma 4 Medulloblastoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Recurrence 3 Osteosarcoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Ependymoma 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2

Interventions

Cisplatin 3 capivasertib 2 Radiosurgery 2 Nivolumab 2 Carboplatin 2 tivozanib 1 pazopanib 1 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 durvalumab 1 copanlisib 1 cemiplimab 1 axicabtagene ciloleucel 1 avasopasem manganese 1 abexinostat 1 Receptors, Interleukin-6 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Fulvestrant 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡